Altamira Therapeutics Ltd. Financial Assets
Altamira Therapeutics Ltd. (CYTOF) had Financial Assets of $1.45 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:FinancialAssets · last filed 2025-04-30
- 2023-12-31: Financial Assets 963.40K CHF.
- 2022-12-31: Financial Assets 486.36K CHF.
- 2021-12-31: Financial Assets 1.46M CHF; Financial Assets as first filed 1.44M CHF.
- 2020-12-31: Financial Assets 11.29M CHF.
CHF
| Period end | Financial Assets | Financial Assets as first filed |
|---|---|---|
| 2023-12-31 | 963.40K CHF 20-F/A · filed 2024-04-22 | |
| 2022-12-31 | 486.36K CHF 20-F/A · filed 2024-04-22 | |
| 2021-12-31 | 1.46M CHF 20-F · filed 2023-05-16 | 1.44M CHF 20-F · filed 2022-04-12 |
| 2020-12-31 | 11.29M CHF 20-F · filed 2022-04-12 | |
| 2019-12-31 | 1.46M CHF 20-F · filed 2020-04-16 | |
| 2018-12-31 | 5.47M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 15.05M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 32.56M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Financial Assets |
|---|---|
| 2024-12-31 | $1.45M 20-F · filed 2025-04-30 |
| 2023-12-31 | $1.14M 20-F · filed 2025-04-30 |
| 2020-12-31 | $11.27M 20-F · filed 2021-03-31 |
| 2019-12-31 | $1.46M 20-F · filed 2021-03-31 |